摘要
阿尔茨海默氏病(AD)是最常见的痴呆症,在老年人中以进行性记忆和认知功能缺失为特征。除了神经元的损伤,老年斑和神经原纤维缠结是AD患者大脑病变中的最大特征。越来越多的证据表明,氧化应激诱导的损伤可能在AD发病的起始和进程中发挥重要作用。产生和抑制氧自由基的失衡导致氧化还原损伤。这些活性氧增加β-淀粉样蛋白和微管相关蛋白高度磷酸化的形成和聚集,反之亦然。目前,还没有治疗该病的有效治法。然而,抗氧化剂的品种繁多,为延迟AD发生或者帮助AD患者改善症状等方面带来希望。本文将总结氧化应激在AD发病机理中的作用和AD的常用抗氧化剂治疗方法。
关键词: 阿尔茨海默氏症;抗氧化剂;氧化应激。
Current Alzheimer Research
Title:Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Volume: 12 Issue: 4
Author(s): Ahmed E. Abdel Moneim
Affiliation:
关键词: 阿尔茨海默氏症;抗氧化剂;氧化应激。
摘要: Alzheimer's disease (AD) is the most common form of dementia characterized by progressive loss of memory and other cognitive functions among older people. Senile plaques and neurofibrillary tangles are the most hallmarks lesions in the brain of AD in addition to neurons loss. Accumulating evidence has shown that oxidative stress–induced damage may play an important role in the initiation and progression of AD pathogenesis. Redox impairment occurs when there is an imbalance between the production and quenching of free radicals from oxygen species. These reactive oxygen species augment the formation and aggregation of amyloid-β and tau protein hyperphosphorylation and vice versa. Currently, there is no available treatments can modify the disease. However, wide varieties of antioxidants show promise to delay or prevent the symptoms of AD and may help in treating the disease. In this review, the role of oxidative stress in AD pathogenesis and the common used antioxidant therapies for AD will summarize.
Export Options
About this article
Cite this article as:
Ahmed E. Abdel Moneim , Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease, Current Alzheimer Research 2015; 12 (4) . https://dx.doi.org/10.2174/1567205012666150325182702
DOI https://dx.doi.org/10.2174/1567205012666150325182702 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design RAGE, Diabetes, and the Nervous System
Current Molecular Medicine Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD
Current Alzheimer Research A Novel Physico-Chemical Property Based Model for Studying the Effects of Mutation on the Aggregation of Peptides
Protein & Peptide Letters GABA Receptors: Pharmacological Potential and Pitfalls
Current Pharmaceutical Design Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets
Current Pharmaceutical Design Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration
Current Topics in Medicinal Chemistry Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
CNS & Neurological Disorders - Drug Targets Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study
CNS & Neurological Disorders - Drug Targets Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Subject Index To Volume 6
Current Molecular Medicine Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents Aging and Proteins: What Does Proteostasis Have to Do with Age?
Current Molecular Medicine Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation
Current Pharmaceutical Design Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters